Your browser doesn't support javascript.
loading
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.
Homan, Claire C; King-Smith, Sarah L; Lawrence, David M; Arts, Peer; Feng, Jinghua; Andrews, James; Armstrong, Mark; Ha, Thuong; Dobbins, Julia; Drazer, Michael W; Yu, Kai; Bödör, Csaba; Cantor, Alan; Cazzola, Mario; Degelman, Erin; DiNardo, Courtney D; Duployez, Nicolas; Favier, Remi; Fröhling, Stefan; Fitzgibbon, Jude; Klco, Jeffery M; Krämer, Alwin; Kurokawa, Mineo; Lee, Joanne; Malcovati, Luca; Morgan, Neil V; Natsoulis, Georges; Owen, Carolyn; Patel, Keyur P; Preudhomme, Claude; Raslova, Hana; Rienhoff, Hugh; Ripperger, Tim; Schulte, Rachael; Tawana, Kiran; Velloso, Elvira; Yan, Benedict; Liu, Paul; Godley, Lucy A; Schreiber, Andreas W; Hahn, Christopher N; Scott, Hamish S; Brown, Anna L.
Afiliación
  • Homan CC; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.
  • King-Smith SL; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.
  • Lawrence DM; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Australian Cancer Research Foundation (ACRF) Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, A
  • Arts P; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.
  • Feng J; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Australian Cancer Research Foundation (ACRF) Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, SA.
  • Andrews J; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.
  • Armstrong M; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.
  • Ha T; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.
  • Dobbins J; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.
  • Drazer MW; Section of Hematology/Oncology, Departments of Medicine and Human Genetics, Center for Clinical Cancer Genetics, and The University of Chicago Comprehensive Cancer Center, The University of Chicago, Chicago, IL.
  • Yu K; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
  • Bödör C; HCEMM-SE Molecular Oncohematology Research Group, 1st Department of P athology and E xperimental Cancer R esearch, Semmelweis U niversity, B udapest, H ungary.
  • Cantor A; Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
  • Cazzola M; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia.
  • Degelman E; Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, AB.
  • DiNardo CD; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Duployez N; Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier Regional Universitaire de Lille, Lille, France; Jean-Pierre Aubert Research Center, INSERM, Universitaire de Lille, Lille.
  • Favier R; Assistance Publique- Hôpitaux de Paris, Armand Trousseau children's Hospital, Paris.
  • Fröhling S; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Fitzgibbon J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London.
  • Klco JM; St Jude Children's Research Hospital, Memphis, Tennessee, United States.
  • Krämer A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Dept. of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Kurokawa M; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan.
  • Lee J; Department of Haematology-Oncology, National University Cancer Institute, National University Health System.
  • Malcovati L; Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia.
  • Morgan NV; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham.
  • Natsoulis G; Imago Biosciences, Inc., San Francisco, CA.
  • Owen C; Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, AB.
  • Patel KP; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Preudhomme C; Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier Regional Universitaire de Lille, Lille, France; Jean-Pierre Aubert Research Center, INSERM, Universitaire de Lille, Lille.
  • Raslova H; Institut Gustave Roussy, Université Paris Sud, Equipe Labellisée par la Ligue Nationale Contre le Cancer, Villejuif.
  • Rienhoff H; Imago Biosciences, Inc., San Francisco, CA.
  • Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Schulte R; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Monroe Carell Jr. Children's Hospital, Vanderbilt University Medical Center, Nashville, TN.
  • Tawana K; Department of Haematology, Addenbrooke's Hospital. Cambridge, CB2 0QQ.
  • Velloso E; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil; Genetics Laboratory, Hospital Israelita Albert Einstein, Sao Paulo,
  • Yan B; Department of Haematology-Oncology, National University Cancer Institute, National University Health System.
  • Liu P; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
  • Godley LA; Section of Hematology/Oncology, Departments of Medicine and Human Genetics, Center for Clinical Cancer Genetics, and The University of Chicago Comprehensive Cancer Center, The University of Chicago, Chicago, IL.
  • Schreiber AW; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; Australian Cancer Research Foundation (ACRF) Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia; School of Biological Sciences, University of Adelaide, Adelaide
  • Hahn CN; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; School of Medicine, University of Adelaide, Adelaide, SA.
  • Scott HS; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia; School of Medicine, University of
  • Brown AL; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; School of Medicine, University of Adelaide, Adelaide, SA. anna.brown@sa.gov.au.
Haematologica ; 106(11): 3004-3007, 2021 11 01.
Article en En | MEDLINE | ID: mdl-34233450
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos de las Plaquetas Sanguíneas / Leucemia Mieloide Aguda / Neoplasias Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article País de afiliación: Arabia Saudita
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos de las Plaquetas Sanguíneas / Leucemia Mieloide Aguda / Neoplasias Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article País de afiliación: Arabia Saudita